Improved outcomes with "upstream" use of glycoprotein IIb/IIIa inhibition prior to early percutaneous coronary intervention after admission for non-ST-segment elevation acute myocardial infarction

被引：0
|
作者：
Greenbaum, AB
Kleiman, NS
Berger, PB
Cohen, DJ
Cannons, CP
Brindis, R
Li, Y
Roe, MT
Harrington, RA
Peterson, E
Gibler, WB
Ohman, EM
机构：
[1] Henry Ford Heart & Vasc Inst, Detroit, MI USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Mayo Clin, Rochester, MN USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Kaiser Permanente Hlth Syst, San Francisco, CA USA
[7] Duke Clin Res Inst, Durham, NC USA
[8] Univ Cincinnati, Sch Med, Cincinnati, OH USA
[9] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72L / 72L
页数：1
相关论文
共 50 条
  • [41] Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes A Systematic Overview of Randomized Clinical Trials
    Tricoci, Pierluigi
    Newby, L. Kristin
    Hasselblad, Vic
    Kong, David F.
    Giugliano, Robert P.
    White, Harvey D.
    Theroux, Pierre
    Stone, Gregg W.
    Moliterno, David J.
    Van de Werf, Frans
    Armstrong, Paul W.
    Prabhakaran, Dorairaj
    Rasoul, Saman
    Bolognese, Leonardo
    Durand, Eric
    Braunwald, Eugene
    Califf, Robert M.
    Harrington, Robert A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 448 - 458
  • [42] Optimal Timing of Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Heart Failure
    Hyun, Dae Young
    Kim, Min Chul
    Jeong, Myung Ho
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Juhan
    Ahn, Youngkeun
    Ahn, Tae Hoon
    Ki-Bae, Seung
    Oh, Dong Joo
    Kim, Hyo-Soo
    Gwon, Hyeon Cheol
    Seong, In Whan
    Chae, Shung
    Kim, Young Jo
    Oh, Seok-Kyu
    Chae, Jei Keon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B279 - B279
  • [43] Glycoprotein IIB/IIIA receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction: An appropriate-use model for the emergency department
    Hoekstra, J
    JOURNAL OF EMERGENCY MEDICINE, 2000, 19 (03): : 13S - 19S
  • [44] Percutaneous Intervention for Non-ST-Segment Elevation Myocardial Infarction Within the Therapeutic Time Window for Acute Myocardial Infarction Reply
    Ting, Henry H.
    Nallamothu, Brahmajee K.
    Krumholz, Harlan M.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (10) : 952 - 952
  • [45] Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction
    Rymer, Jennifer A.
    Tempelhof, Michael W.
    Clare, Robert M.
    Pieper, Karen S.
    Granger, Christopher B.
    Van de Werf, Frans
    Moliterno, David J.
    Harrington, Robert A.
    White, Harvey D.
    Armstrong, Paul W.
    Lopes, Renato D.
    Mahaffey, Kenneth W.
    Newby, L. Kristin
    AMERICAN HEART JOURNAL, 2018, 201 : 103 - 110
  • [46] Differences among GP IIb/IIIa inhibitors: different clinical benefits in non-ST-segment elevation acute coronary syndrome percutaneous coronary intervention patients
    Antoniucci, David
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2007, 9 (0A) : A32 - A36
  • [47] Seasonal Variation in the Outcomes of Acute Non-ST-Segment Elevation Myocardial Infarction
    Javaid, Huzaifa
    Ashraf, Muddasir
    Bajwa, Tanvir
    Allaqaband, Suhail
    Jan, M. Fuad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B5 - B6
  • [48] Safety and Efficacy of Adjuvant Glycoprotein IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention Performed From the Radial Approach for Acute ST Segment Elevation Myocardial Infarction
    Iqbal, Zafar
    Cohen, Marc
    Pollack, Charles
    Goldstein, Patrick
    Zeymer, Uwe
    Huber, Kurt
    Barthelemy, Olivier
    Cayla, Guillaume
    Aout, Mounir
    Vicaut, Eric
    Montalescot, Gilles
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (12): : 1727 - 1733
  • [49] Regional and gender differences in the access to early percutaneous coronary intervention for non-ST-Segment elevation acute coronary syndromes:: Experience from the PURSUIT trial with glycoprotein IIb-IIIa inhibitor eptifibatide (INTEGRILIN®)
    Lorenz, TJ
    Greenberg, S
    Kitt, MM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 87A - 87A
  • [50] GLYCOPROTEIN IIB/IIIA INHIBITORS WITH UPSTREAM OR DOWNSTREAM THIENOPYRIDINE USE IMPROVE OUTCOMES AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN HIGH RISK PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION- A METAREGRESSION OF RANDOMIZED CONTROLLED TRIALS
    Sethi, Ankur
    Bajaj, Anurag
    Bahekar, Amol
    Bhuriya, Rohit
    Singh, Param
    Singh, Mukesh
    Ahmed, Aziz
    Khosla, Sandeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E260 - E260
12345